These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12879447)

  • 1. Distinctions between c-Rel and other NF-kappaB proteins in immunity and disease.
    Liou HC; Hsia CY
    Bioessays; 2003 Aug; 25(8):767-80. PubMed ID: 12879447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular profiling of the role of the NF-kappaB family of transcription factors during alloimmunity.
    Finn PW; He H; Ma C; Mueller T; Stone JR; Liou HC; Boothby MR; Perkins DL
    J Leukoc Biol; 2002 Nov; 72(5):1054-62. PubMed ID: 12429729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Rel but not NF-kappaB1 is important for T regulatory cell development.
    Deenick EK; Elford AR; Pellegrini M; Hall H; Mak TW; Ohashi PS
    Eur J Immunol; 2010 Mar; 40(3):677-81. PubMed ID: 20082358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kickstarting Foxp3 with c-Rel.
    Hsieh CS
    Immunity; 2009 Dec; 31(6):852-3. PubMed ID: 20064443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The c-Rel transcription factor and B-cell proliferation: a deal with the devil.
    Gilmore TD; Kalaitzidis D; Liang MC; Starczynowski DT
    Oncogene; 2004 Mar; 23(13):2275-86. PubMed ID: 14755244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in kappaB DNA-binding properties of v-Rel and c-Rel are the result of oncogenic mutations in three distinct functional regions of the Rel protein.
    Nehyba J; Hrdlicková R; Bose HR
    Oncogene; 1997 Jun; 14(24):2881-97. PubMed ID: 9205096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant rel/nfkb genes and activity in human cancer.
    Rayet B; Gélinas C
    Oncogene; 1999 Nov; 18(49):6938-47. PubMed ID: 10602468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF-kappaB inducible genes BCL-X and cyclin E promote immature B-cell proliferation and survival.
    Feng B; Cheng S; Hsia CY; King LB; Monroe JG; Liou HC
    Cell Immunol; 2004; 232(1-2):9-20. PubMed ID: 15922711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cg-Rel, the first Rel/NF-kappaB homolog characterized in a mollusk, the Pacific oyster Crassostrea gigas.
    Montagnani C; Kappler C; Reichhart JM; Escoubas JM
    FEBS Lett; 2004 Mar; 561(1-3):75-82. PubMed ID: 15013754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Members of the NF-kappaB family expressed in zones of active neurogenesis in the postnatal and adult mouse brain.
    Denis-Donini S; Caprini A; Frassoni C; Grilli M
    Brain Res Dev Brain Res; 2005 Jan; 154(1):81-9. PubMed ID: 15617758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Rel phenocopies PKCtheta but not Bcl-10 in regulating CD8+ T-cell activation versus tolerance.
    Deenick EK; Po L; Chapatte L; Murakami K; Lu YC; Elford AR; Saibil SD; Ruland J; Gerondakis S; Mak TW; Ohashi PS
    Eur J Immunol; 2010 Mar; 40(3):867-77. PubMed ID: 19950170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. To be, or not to be: NF-kappaB is the answer--role of Rel/NF-kappaB in the regulation of apoptosis.
    Kucharczak J; Simmons MJ; Fan Y; Gélinas C
    Oncogene; 2003 Dec; 22(56):8961-82. PubMed ID: 14663476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel.
    Gilmore TD; Cormier C; Jean-Jacques J; Gapuzan ME
    Oncogene; 2001 Oct; 20(48):7098-103. PubMed ID: 11704834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct nuclear factor-kappaB/Rel proteins have opposing modulatory effects in glutamate-induced cell death in HT22 cells.
    Ishige K; Tanaka M; Arakawa M; Saito H; Ito Y
    Neurochem Int; 2005 Dec; 47(8):545-55. PubMed ID: 16183169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual apoptotic effect of Xrel3 c-Rel/NF-kappaB homolog in human cervical cancer cells.
    Shehata M; Shehata M; Shehata F; Pater A
    Cell Biol Int; 2004; 28(12):895-904. PubMed ID: 15566959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of NF-kappaB/Rel transcription factors in human primary peripheral blood mononuclear cells by interleukin 7.
    Lamberti A; Petrella A; Pascale M; Romano MF; Bisogni R; Vita N; Venuta S; Turco MC
    Biol Chem; 2004 May; 385(5):415-7. PubMed ID: 15196001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nuclear factor kappaB subunits RelA/p65 and c-Rel potentiate but are not required for Ras-induced cellular transformation.
    Hanson JL; Hawke NA; Kashatus D; Baldwin AS
    Cancer Res; 2004 Oct; 64(20):7248-55. PubMed ID: 15492243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel.
    Gilmore TD
    Oncogene; 1999 Nov; 18(49):6925-37. PubMed ID: 10602467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divergent C-terminal transactivation domains of Rel/NF-kappa B proteins are critical determinants of their oncogenic potential in lymphocytes.
    Fan Y; Rayet B; Gélinas C
    Oncogene; 2004 Feb; 23(5):1030-42. PubMed ID: 14647412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF-kappaB factor c-Rel mediates neuroprotection elicited by mGlu5 receptor agonists against amyloid beta-peptide toxicity.
    Pizzi M; Sarnico I; Boroni F; Benarese M; Steimberg N; Mazzoleni G; Dietz GP; Bähr M; Liou HC; Spano PF
    Cell Death Differ; 2005 Jul; 12(7):761-72. PubMed ID: 15818410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.